Australia's Island Pharmaceuticals rises on US government collaboration

Island Pharmaceuticals

04/03/2026 03:12

** Shares of Island Pharmaceuticals ILA.AX rise as much as 18.9% to A$0.44, their highest level since February 9

** Antiviral drug developer enters cooperative research and development agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases

** Agreement to advance Galidesivir under the U.S. Food and Drug Administration's (FDA) Animal Rule development pathway for the treatment of Marburg virus disease, says co

** Galidesivir is a clinical-stage antiviral molecule used against high-priority threats such as Ebola, Marburg, MERS, Zika and Yellow fever, says co

** YTD, stock down 4.7%, including the day's move

 (Reporting by Sherin Sunny in Bengaluru)

 ((Sherin.Sunny@thomsonreuters.com))